1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition
- Leptin receptor antagonism of iNKT cell function : a novel strategy to combat multiple myeloma
- Immune therapy in multiple myeloma : can iNKT cells be targeted?
- Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells
- 2016
- Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?
- 2013
- Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model